Phase II study of dendritic cell vaccination combined with recombinant adenovirus-p53 in treatment for patients with advanced pancreatic carcinoma.
/in Dendritic Cells, Pancreatic Cancer /von 2013-06-03 / J Clin Oncol 31, 2013 (suppl; abstr 3049)Immunogenicity of dendritic cells pulsed with MAGE3, Survivin and B-cell maturation antigen mRNA for vaccination of multiple myeloma patients
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2013-06-02 / Cancer Immunol. Immunother. 2013 Aug;62(8):1381-92Allogeneic dendritic cell (DC) vaccination as an “off the shelf” treatment to prevent or delay relapse in elderly acute myeloid leukemia patients: Results of phase I study.
/in Acute Leukemia, Dendritic Cells, International Publications /von 2013-06-01 / J Clin Oncol 31, 2013 (suppl; abstr 3029)Impact of dendritic cells combining with cytokine-induced killer cells synergized chemotherapy in patients of advanced non-small cell lung cancer.
/in Dendritic Cells, NSCLC /von 2013-05-31 / J Clin Oncol 31, 2013 (suppl; abstr e19018)Vaccination of diffuse large B- cell lymphoma patients with antigen-primed dendritic cells
/in Dendritic Cells, International Publications, Malignant Lymphoma /von 2013-05-30 / Acta Med Iran 2013 May;51(5):284-8Autologous tumor lysate-pulsed dendritic cell immunotherapy for pediatric patients with newly diagnosed or recurrent high-grade gliomas
/in Brain Tumors in Children, Dendritic Cells, International Publications /von 2013-05-01 / Anticancer Res. 2013 May;33(5):2047-56Dendritic cell immunotherapy combined with gemcitabine chemotherapy enhances survival in a murine model of pancreatic carcinoma
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2013-04-19 / Cancer Immunol. Immunother. 2013 Jun;62(6):1083-91Therapeutic regulation of myeloid-derived suppressor cells and immune response to cancer vaccine in patients with extensive stage small cell lung cancer
/in Dendritic Cells, International Publications, SCLC /von 2013-04-16 / Cancer Immunol. Immunother. 2013 May;62(5):909-18Blockade of PD-1/PD-L1 immune checkpoint during DC vaccination induces potent protective immunity against breast cancer in hu-SCID mice
/in Checkpoint-Inhibitors, Dendritic Cells, International Publications /von 2013-03-21 / Cancer Lett. 2013 Aug;336(2):253-9
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de